{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:28:17Z","timestamp":1786577297014,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008637","name":"Center for Strategic Scientific Initiatives, National Cancer Institute","doi-asserted-by":"publisher","award":["5P30 CA023108-41"],"award-info":[{"award-number":["5P30 CA023108-41"]}],"id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["S10 1S10OD030242"],"award-info":[{"award-number":["S10 1S10OD030242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01666-8","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:58:35Z","timestamp":1779443915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Continuous DNA methylation deconvolution-based surrogate for B-cell differentiation state in chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7221-5680","authenticated-orcid":false,"given":"Jeffrey","family":"Hage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Wainman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiyinfoluwa","family":"Kolawole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-9901","authenticated-orcid":false,"given":"Fred","family":"Kolling IV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6429-5192","authenticated-orcid":false,"given":"Pauline","family":"Patzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schoolcraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Spracklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3022-426X","authenticated-orcid":false,"given":"Brock","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"1666_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ajh.27546","volume":"100","author":"M Hallek","year":"2025","unstructured":"Hallek, M. Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy. Am. J. Hematol. 100, 450\u2013480 (2025).","journal-title":"Am. J. Hematol."},{"key":"1666_CR2","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle, R. N. et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia: presented in part at the 40th Annual Meeting of The American Society of Hematology, held in Miami Beach, FL, December 4-8, 1998. Blood 94, 1840\u20131847 (1999).","journal-title":"Blood"},{"key":"1666_CR3","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G. & Stevenson, F. K. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94, 1848\u20131854 (1999).","journal-title":"Blood"},{"key":"1666_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.leu.2404457","volume":"21","author":"P Ghia","year":"2007","unstructured":"Ghia, P. et al. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 21, 1\u20133 (2007).","journal-title":"Leukemia"},{"key":"1666_CR5","doi-asserted-by":"publisher","first-page":"107541","DOI":"10.1016\/j.leukres.2024.107541","volume":"143","author":"P Galieni","year":"2024","unstructured":"Galieni, P. et al. Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT). Leuk. Res. 143, 107541 (2024).","journal-title":"Leuk. Res."},{"key":"1666_CR6","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3324\/haematol.2019.220194","volume":"105","author":"EC Rotbain","year":"2020","unstructured":"Rotbain, E. C. et al. IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study. Haematologica 105, 1621\u20131629 (2020).","journal-title":"Haematologica"},{"key":"1666_CR7","doi-asserted-by":"publisher","first-page":"678\u2013685.e4","DOI":"10.1016\/j.clml.2019.03.002","volume":"19","author":"A Visentin","year":"2019","unstructured":"Visentin, A. et al. Prognostic and predictive effect of IGHV mutational status and load in chronic lymphocytic leukemia: focus on FCR and BR treatments. Clin. Lymphoma Myeloma Leuk. 19, 678\u2013685.e4 (2019).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"1666_CR8","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","volume":"54","author":"BA Knisbacher","year":"2022","unstructured":"Knisbacher, B. A. et al. Molecular map of chronic lymphocytic leukemia and its impact on outcome. Nat. Genet. 54, 1664\u20131674 (2022).","journal-title":"Nat. Genet."},{"key":"1666_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1182\/blood-2008-01-131359","volume":"112","author":"FJ Li","year":"2008","unstructured":"Li, F. J. et al. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 112, 179\u2013187 (2008).","journal-title":"Blood"},{"key":"1666_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/leu.2014.252","volume":"29","author":"AC Queir\u00f3s","year":"2015","unstructured":"Queir\u00f3s, A. C. et al. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact. Leukemia 29, 598\u2013605 (2015).","journal-title":"Leukemia"},{"key":"1666_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.hoc.2004.04.004","volume":"18","author":"F Caligaris-Cappio","year":"2004","unstructured":"Caligaris-Cappio, F. & Ghia, P. The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model. Hematol.\/Oncol. Clin. 18, 849\u2013862 (2004).","journal-title":"Hematol.\/Oncol. Clin."},{"key":"1666_CR12","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","volume":"117","author":"N Chiorazzi","year":"2011","unstructured":"Chiorazzi, N. & Ferrarini, M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 117, 1781\u20131791 (2011).","journal-title":"Blood"},{"key":"1666_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ng.2443","volume":"44","author":"M Kulis","year":"2012","unstructured":"Kulis, M. et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat. Genet. 44, 1236\u20131242 (2012).","journal-title":"Nat. Genet."},{"key":"1666_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.3488","volume":"48","author":"CC Oakes","year":"2016","unstructured":"Oakes, C. C. et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat. Genet. 48, 253\u2013264 (2016).","journal-title":"Nat. Genet."},{"key":"1666_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1182\/blood.2019000490","volume":"134","author":"B Giacopelli","year":"2019","unstructured":"Giacopelli, B. et al. Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia. Blood 134, 688\u2013698 (2019).","journal-title":"Blood"},{"key":"1666_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00724-7","volume":"12","author":"JA Wierzbinska","year":"2020","unstructured":"Wierzbinska, J. A. et al. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL. Genome. Med. 12, 29 (2020).","journal-title":"Genome. Med."},{"key":"1666_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-86","volume":"13","author":"EA Houseman","year":"2012","unstructured":"Houseman, E. A. et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinforma. 13, 86 (2012).","journal-title":"BMC Bioinforma."},{"key":"1666_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27864-7","volume":"13","author":"LA Salas","year":"2022","unstructured":"Salas, L. A. et al. Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling. Nat. Commun. 13, 761 (2022).","journal-title":"Nat. Commun."},{"key":"1666_CR19","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363\u20131369 (2014).","journal-title":"Bioinformatics"},{"key":"1666_CR20","first-page":"e123","volume":"46","author":"W Zhou","year":"2018","unstructured":"Zhou, W., Triche Jr, T. J., Laird, P. W. & Shen, H. SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions. Nucleic Acids Res. 46, e123 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1666_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01207-1","volume":"13","author":"Z Xu","year":"2021","unstructured":"Xu, Z., Niu, L. & Taylor, J. A. The ENmix DNA methylation analysis pipeline for Illumina BeadChip and comparisons with seven other preprocessing pipelines. Clin. Epigenetics 13, 216 (2021).","journal-title":"Clin. Epigenetics"},{"key":"1666_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-0943-7","volume":"17","author":"DC Koestler","year":"2016","unstructured":"Koestler, D. C. et al. Improving cell mixture deconvolution by identifying optimal DNA methylation libraries (IDOL). BMC Bioinforma. 17, 120 (2016).","journal-title":"BMC Bioinforma."},{"key":"1666_CR23","unstructured":"Salas, L. A. & Zhang, Z. FlowSorted.BloodExtended.EPIC: Illumina EPIC Data on Extended Immunomagnetic Sorted Blood Populations. https:\/\/github.com\/immunomethylomics\/FlowSorted.BloodExtended.EPIC (2021). R package version 0.99.0, commit 1a2e43ae956e8d886b672f1098d9f363c272549e."},{"key":"1666_CR24","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/bioinformatics\/bty778","volume":"35","author":"C Xie","year":"2019","unstructured":"Xie, C. et al. Differential methylation values in differential methylation analysis. Bioinformatics 35, 1094\u20131097 (2019).","journal-title":"Bioinformatics"},{"key":"1666_CR25","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1666_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btv560","volume":"32","author":"B Phipson","year":"2016","unstructured":"Phipson, B., Maksimovic, J. & Oshlack, A. missMethyl: an R package for analyzing data from Illumina\u2019s HumanMethylation450 platform. Bioinformatics 32, 286\u2013288 (2016).","journal-title":"Bioinformatics"},{"key":"1666_CR27","unstructured":"Gu, Z.IlluminaHumanMethylationEPICv2anno.20a1.hg38: Annotation for Illumina\u2019s EPIC v2.0 methylation arrays. https:\/\/github.com\/jokergoo\/IlluminaHumanMethylationEPICv2anno.20a1.hg38 (2024). R package version 1.0.0, commit 702e52acb8268353bd8c753e67a2096c565f9782."},{"key":"1666_CR28","unstructured":"Morgan, M. & Shepherd, L. AnnotationHub: Client to access AnnotationHub resources. https:\/\/bioconductor.org\/packages\/AnnotationHub (2024). R package version 3.14.0."},{"key":"1666_CR29","unstructured":"Wanding, Z. & David, G. knowYourCG: Functional Analysis of DNA Methylome Datasets. https:\/\/bioconductor.org\/packages\/knowYourCG (2024). R package version 1.2.5."},{"key":"1666_CR30","doi-asserted-by":"publisher","first-page":"eadw3027","DOI":"10.1126\/sciadv.adw3027","volume":"11","author":"DC Goldberg","year":"2025","unstructured":"Goldberg, D. C. et al. KnowYourCG: facilitating base-level sparse methylome interpretation. Sci. Adv. 11, eadw3027 (2025).","journal-title":"Sci. Adv."},{"key":"1666_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01399-0","volume":"14","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Comparative analysis of the DNA methylation landscape in CD4, CD8, and B memory lineages. Clin. Epigenetics 14, 173 (2022).","journal-title":"Clin. Epigenetics"},{"key":"1666_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/1948550617697177","volume":"8","author":"D Lakens","year":"2017","unstructured":"Lakens, D. Equivalence tests: a practical primer for t tests, correlations, and meta-analyses. Soc. Psychol. Personal. Sci. 8, 355\u2013362 (2017).","journal-title":"Soc. Psychol. Personal. Sci."},{"key":"1666_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-020-0456-0","volume":"7","author":"DY Yosifov","year":"2020","unstructured":"Yosifov, D. Y. et al. DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy. Sci. Data 7, 133 (2020).","journal-title":"Sci. Data"},{"key":"1666_CR34","doi-asserted-by":"publisher","first-page":"e70211","DOI":"10.1002\/hem3.70211","volume":"10","author":"S Charalampopoulou","year":"2026","unstructured":"Charalampopoulou, S. et al. Identification of two epitypes of IGHV unmutated chronic lymphocytic leukemia with distinct B-cell-related epigenetic imprinting and genetic alterations. HemaSphere 10, e70211 (2026).","journal-title":"HemaSphere"},{"key":"1666_CR35","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, Vienna, Austria). https:\/\/www.R-project.org\/ (2024)."},{"key":"1666_CR36","doi-asserted-by":"publisher","first-page":"e92209","DOI":"10.1371\/journal.pone.0092209","volume":"9","author":"J Keilwagen","year":"2014","unstructured":"Keilwagen, J., Grosse, I. & Grau, J. Area under precision-recall curves for weighted and unweighted data. PLoS ONE 9, e92209 (2014).","journal-title":"PLoS ONE"},{"key":"1666_CR37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1158\/2159-8290.CD-13-0349","volume":"4","author":"CC Oakes","year":"2014","unstructured":"Oakes, C. C. et al. Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. Cancer Discov. 4, 348\u2013361 (2014).","journal-title":"Cancer Discov."},{"key":"1666_CR38","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/ng.3291","volume":"47","author":"M Kulis","year":"2015","unstructured":"Kulis, M. et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat. Genet. 47, 746\u2013756 (2015).","journal-title":"Nat. Genet."},{"key":"1666_CR39","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/s41375-018-0045-9","volume":"32","author":"N Schleussner","year":"2018","unstructured":"Schleussner, N. et al. The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17\/ILC3 skewing of anaplastic large cell lymphoma. Leukemia 32, 1994\u20132007 (2018).","journal-title":"Leukemia"},{"key":"1666_CR40","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/s41588-022-01241-6","volume":"54","author":"S Kaluscha","year":"2022","unstructured":"Kaluscha, S. et al. Evidence that direct inhibition of transcription factor binding is the prevailing mode of gene and repeat repression by DNA methylation. Nat. Genet. 54, 1895\u20131906 (2022).","journal-title":"Nat. Genet."},{"key":"1666_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343\u2013349 (2011).","journal-title":"Nature"},{"key":"1666_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1101\/gad.1886410","volume":"24","author":"G Li","year":"2010","unstructured":"Li, G. et al. Jarid2 and PRC2, partners in regulating gene expression. Genes. Dev. 24, 368\u2013380 (2010).","journal-title":"Genes. Dev."},{"key":"1666_CR43","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1073\/pnas.1116418109","volume":"109","author":"MT McCabe","year":"2012","unstructured":"McCabe, M. T. et al. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc. Natl. Acad. Sci. USA 109, 2989\u20132994 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1666_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/ni876","volume":"4","author":"I-h Su","year":"2003","unstructured":"Su, I. -h. et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4, 124\u2013131 (2003).","journal-title":"Nat. Immunol."},{"key":"1666_CR45","doi-asserted-by":"publisher","first-page":"e68227","DOI":"10.7554\/eLife.68227","volume":"10","author":"K-i Hirano","year":"2021","unstructured":"Hirano, K. -i. et al. LMO2 is essential to maintain the ability of progenitors to differentiate into T-cell lineage in mice. eLife 10, e68227 (2021).","journal-title":"eLife"},{"key":"1666_CR46","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1182\/blood-2005-08-3145","volume":"107","author":"C Capron","year":"2006","unstructured":"Capron, C. et al. The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood 107, 4678\u20134686 (2006).","journal-title":"Blood"},{"key":"1666_CR47","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1182\/blood-2012-09-458570","volume":"122","author":"MP McCormack","year":"2013","unstructured":"McCormack, M. P. et al. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. Blood 122, 2093\u20132103 (2013).","journal-title":"Blood"},{"key":"1666_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02068-2","volume":"10","author":"A Turk","year":"2024","unstructured":"Turk, A., \u010ceh, E., Calin, G. A. & Kunej, T. Multiple omics levels of chronic lymphocytic leukemia. Cell Death Discov. 10, 293 (2024).","journal-title":"Cell Death Discov."},{"key":"1666_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-020-00446-2","volume":"21","author":"BJ Laidlaw","year":"2021","unstructured":"Laidlaw, B. J. & Cyster, J. G. Transcriptional regulation of memory B cell differentiation. Nat. Rev. Immunol. 21, 209\u2013220 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"1666_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-102","volume":"12","author":"C Zhou","year":"2013","unstructured":"Zhou, C. et al. MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1. Mol. Cancer 12, 102 (2013).","journal-title":"Mol. Cancer"},{"key":"1666_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41419-021-03729-1","volume":"12","author":"C-L Lin","year":"2021","unstructured":"Lin, C.-L. et al. MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1\/MEK3\/p38\/YB1 axis. Cell Death Dis. 12, 451 (2021).","journal-title":"Cell Death Dis."},{"key":"1666_CR52","doi-asserted-by":"publisher","first-page":"e62986","DOI":"10.1371\/journal.pone.0062986","volume":"8","author":"H Dong","year":"2013","unstructured":"Dong, H. et al. The metastasis-associated gene MTA3, a component of the Mi-2\/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma. PloS ONE 8, e62986 (2013).","journal-title":"PloS ONE"},{"key":"1666_CR53","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.18632\/oncotarget.6281","volume":"7","author":"J-H Liang","year":"2015","unstructured":"Liang, J.-H. et al. Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia. Oncotarget 7, 2135\u20132142 (2015).","journal-title":"Oncotarget"},{"key":"1666_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-5-22","volume":"5","author":"R Dolcetti","year":"2010","unstructured":"Dolcetti, R. & Carbone, A. Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor? Infect. Agents Cancer 5, 22 (2010).","journal-title":"Infect. Agents Cancer"},{"key":"1666_CR55","doi-asserted-by":"publisher","unstructured":"Hage, J. Code for: Continuous DNA methylation deconvolution-based surrogate for B-cell differentiation state in chronic lymphocytic leukemia. https:\/\/doi.org\/10.5281\/zenodo.17118029 (2026).","DOI":"10.5281\/zenodo.17118029"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01666-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01666-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01666-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:04:48Z","timestamp":1786575888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01666-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1666"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01666-8","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Christensen is a co-founder of Cellintec, which had no role in this work; the remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"441"}}